European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2030

Conditions

Endometrial Cancer

Interventions

PROCEDURE

Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)

Trial Locations (1)

RECRUITING

University Hospital Essen, Department of Gynaecology, Essen

All Listed Sponsors

lead

Dr. Paul Buderath

OTHER